PHARMACOLOGICAL CHARACTERIZATION OF BENZODIAZEPINE WITHDRAWAL IN THE ELEVATED PLUS-MAZE TEST OF ANXIETY

被引:0
|
作者
BALDWIN, HA [1 ]
FILE, SE [1 ]
机构
[1] UNIV LONDON,SCH PHARM,LONDON,ENGLAND
关键词
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页码:S4 / S4
页数:1
相关论文
共 50 条
  • [1] EFFECTS OF BENZODIAZEPINE RECEPTOR PARTIAL INVERSE AGONISTS IN THE ELEVATED PLUS-MAZE TEST OF ANXIETY IN THE RAT
    COLE, BJ
    HILLMANN, M
    SEIDELMANN, D
    KLEWER, M
    JONES, GH
    PSYCHOPHARMACOLOGY, 1995, 121 (01) : 118 - 126
  • [2] Assessment of amphetamine withdrawal anxiety-like behavior in the elevated plus-maze test in rats
    Koltunowska, Dorota
    Gibula-Bruzda, Ewa
    Kotlinska, Jolanta H.
    PHARMACOLOGICAL REPORTS, 2011, 63 (02) : 560 - 561
  • [3] Assessment of amphetamine withdrawal anxiety-like behavior in the elevated plus-maze test in rats
    Dorota Kołtunowska
    Ewa Gibuła-Bruzda
    Jolanta H. Kotlińska
    Pharmacological Reports, 2011, 63 (2) : 560 - 561
  • [4] THE ELEVATED PLUS-MAZE TEST OF ANXIETY - FURTHER BEHAVIORAL VALIDATION
    BALDWIN, HA
    FILE, SE
    PSYCHOPHARMACOLOGY, 1986, 89 (04) : S8 - S8
  • [5] Structure of the mouse behaviour on the elevated plus-maze test of anxiety
    Espejo, EF
    BEHAVIOURAL BRAIN RESEARCH, 1997, 86 (01) : 105 - 112
  • [6] Anxiety, defence and the elevated plus-maze
    Rodgers, RJ
    Dalvi, A
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1997, 21 (06): : 801 - 810
  • [7] SODIUM VALPROATE AND CHLORDIAZEPOXIDE IN THE ELEVATED PLUS-MAZE TEST OF ANXIETY IN THE RAT
    FILE, SE
    ARANKO, K
    NEUROPSYCHOBIOLOGY, 1988, 20 (02) : 82 - 86
  • [8] VIGABATRIN HAS AN ANXIOLYTIC EFFECT IN THE ELEVATED PLUS-MAZE TEST OF ANXIETY
    SAYIN, U
    PURALI, N
    OZKAN, T
    ALTUG, T
    BUYUKDEVRIM, S
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1992, 43 (02) : 529 - 535
  • [9] THE INTERPLAY OF LEARNING AND ANXIETY IN THE ELEVATED PLUS-MAZE
    FILE, SE
    BEHAVIOURAL BRAIN RESEARCH, 1993, 58 (1-2) : 199 - 202
  • [10] The gerbil elevated plus-maze I: Behavioral characterization and pharmacological validation
    Varty, GB
    Morgan, CA
    Cohen-Williams, ME
    Coffin, VL
    Carey, GJ
    NEUROPSYCHOPHARMACOLOGY, 2002, 27 (03) : 357 - 370